Robert Bain Thomas

Robert Bain Thomas has filed trades across 2 companies (mainly through SEC (Form 4)), most often in REVA Medical, Inc. and HeartWare International, Inc. Over a trading history stretching from 31 March 2016 to 29 June 2018, the count stands at 18 filings.

Every open-market trade on record is a purchase: 11 purchases worth €300k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants and 3 option exercises. So far in 2018, the count stands at 7 purchases and no sales.

In size, the median ticket on the buying side is €12k. On 3 out of 11 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 2 July 2018: an open-market purchase of €22k, in REVA Medical, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.